What is the address of IMAGERIE MEDICALE DEFRERE?

The registered office of IMAGERIE MEDICALE DEFRERE is located at Rue des Villas 63, 4100 Seraing.

Is IMAGERIE MEDICALE DEFRERE still active?

Yes. According to the CBE (29 September 2026) IMAGERIE MEDICALE DEFRERE is active, legal situation “Normale toestand”, started on 30 November 2011.

Is IMAGERIE MEDICALE DEFRERE registered on Peppol?

No, IMAGERIE MEDICALE DEFRERE is currently not registered on the Peppol network.

What is the enterprise number of IMAGERIE MEDICALE DEFRERE?

The enterprise number of IMAGERIE MEDICALE DEFRERE is BE0841433725.

When was IMAGERIE MEDICALE DEFRERE founded?

IMAGERIE MEDICALE DEFRERE was founded on 30 November 2011.

Who are the directors of IMAGERIE MEDICALE DEFRERE?

According to the 2025 annual accounts, the directors of IMAGERIE MEDICALE DEFRERE are: Florence Lacroix, Pierre Defrère.

Is IMAGERIE MEDICALE DEFRERE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 November 2011; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did IMAGERIE MEDICALE DEFRERE make in 2025?

IMAGERIE MEDICALE DEFRERE posted a profit after taxes of € 71,660 in financial year 2025.

What is the revenue of IMAGERIE MEDICALE DEFRERE?

As a small company, IMAGERIE MEDICALE DEFRERE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 113,744.

IMAGERIE MEDICALE DEFRERE (Private Limited) - Seraing

Dossier IMAGERIE MEDICALE DEFRERE, printed on 29 September 2026 from databakkes.be/en/0841433725/imagerie-medicale-defrere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

IMAGERIE MEDICALE DEFRERE from Seraing, company number BE0841433725, closed financial year 2025 with a result of € 71,660 after tax. For that financial year IMAGERIE MEDICALE DEFRERE recorded a gross margin of € 113,744 and equity of € 178,880. Compared with financial year 2024, the result moved from € 69,213 to € 71,660. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Healthy

€ 178,880

▼ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 71,660

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 90,874

▲ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 116,008 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 7,507

▼ 57% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 73,244

▼ 27% vs 2024

€ 20,213 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 2,540

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 21,849

▲ 16% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 259,702 Revenue 2022: € 259,702 First fiscal year in the series	-	-	-
Gross margin	€ 95,150 Gross margin 2022: € 95,150 First fiscal year in the series	€ 91,830 Gross margin 2023: € 91,830 ▼ 3% vs 2022 (€ 95,150) Unfavourable step	€ 127,943 Gross margin 2024: € 127,943 ▲ 39% vs 2023 (€ 91,830) Favourable step	€ 113,744 Gross margin 2025: € 113,744 ▼ 11% vs 2024 (€ 127,943) Unfavourable step	▼ 11%
Profit after taxes	€ 52,093 Profit after taxes 2022: € 52,093 First fiscal year in the series	€ 35,016 Profit after taxes 2023: € 35,016 ▼ 33% vs 2022 (€ 52,093) Unfavourable step	€ 69,213 Profit after taxes 2024: € 69,213 ▲ 98% vs 2023 (€ 35,016) Favourable step	€ 71,660 Profit after taxes 2025: € 71,660 ▲ 4% vs 2024 (€ 69,213) Favourable step	▲ 4%
Equity	€ 198,532 Equity 2022: € 198,532 First fiscal year in the series	€ 200,084 Equity 2023: € 200,084 ▲ 1% vs 2022 (€ 198,532) Favourable step	€ 223,229 Equity 2024: € 223,229 ▲ 12% vs 2023 (€ 200,084) Favourable step	€ 178,880 Equity 2025: € 178,880 ▼ 20% vs 2024 (€ 223,229) Unfavourable step	▼ 20%
Total debts	€ 142,036 Total debts 2022: € 142,036 First fiscal year in the series	€ 142,478 Total debts 2023: € 142,478 Unchanged (€ 142,036) Unfavourable step	€ 176,953 Total debts 2024: € 176,953 ▲ 24% vs 2023 (€ 142,478) Unfavourable step	€ 160,090 Total debts 2025: € 160,090 ▼ 10% vs 2024 (€ 176,953) Favourable step	▼ 10%
Cash	€ 103,711 Cash 2022: € 103,711 First fiscal year in the series	€ 111,174 Cash 2023: € 111,174 ▲ 7% vs 2022 (€ 103,711) Favourable step	€ 86,891 Cash 2024: € 86,891 ▼ 22% vs 2023 (€ 111,174) Unfavourable step	€ 90,874 Cash 2025: € 90,874 ▲ 5% vs 2024 (€ 86,891) Favourable step	▲ 5%
Land & buildings	€ 120,000 Land & buildings 2022: € 120,000 First fiscal year in the series	€ 120,000 Land & buildings 2023: € 120,000 Unchanged (€ 120,000) Unchanged	€ 120,000 Land & buildings 2024: € 120,000 Unchanged (€ 120,000) Unchanged	€ 120,000 Land & buildings 2025: € 120,000 Unchanged (€ 120,000) Unchanged
Retained profit	€ 186,132 Retained profit 2022: € 186,132 First fiscal year in the series	€ 187,684 Retained profit 2023: € 187,684 ▲ 1% vs 2022 (€ 186,132) Favourable step	€ 223,043 Retained profit 2024: € 223,043 ▲ 19% vs 2023 (€ 187,684) Favourable step	€ 178,694 Retained profit 2025: € 178,694 ▼ 20% vs 2024 (€ 223,043) Unfavourable step	▼ 20%
Dividend	€ 4,635 Dividend 2022: € 4,635 First fiscal year in the series	€ 33,423 Dividend 2023: € 33,423 ▲ € 28,788 vs 2022 (€ 4,635) Unchanged	€ 46,068 Dividend 2024: € 46,068 ▲ 38% vs 2023 (€ 33,423) Unchanged	€ 116,008 Dividend 2025: € 116,008 ▲ 152% vs 2024 (€ 46,068) Unchanged	▲ 152%
Bank debt	€ 108,850 Bank debt 2022: € 108,850 First fiscal year in the series	€ 88,240 Bank debt 2023: € 88,240 ▼ 19% vs 2022 (€ 108,850) Favourable step	€ 100,547 Bank debt 2024: € 100,547 ▲ 14% vs 2023 (€ 88,240) Unfavourable step	€ 73,244 Bank debt 2025: € 73,244 ▼ 27% vs 2024 (€ 100,547) Favourable step	▼ 27%
Balance sheet total	€ 340,567 Balance sheet total 2022: € 340,567 First fiscal year in the series	€ 342,562 Balance sheet total 2023: € 342,562 ▲ 1% vs 2022 (€ 340,567) Unchanged	€ 400,181 Balance sheet total 2024: € 400,181 ▲ 17% vs 2023 (€ 342,562) Unchanged	€ 338,970 Balance sheet total 2025: € 338,970 ▼ 15% vs 2024 (€ 400,181) Unchanged	▼ 15%

Key figures of IMAGERIE MEDICALE DEFRERE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to IMAGERIE MEDICALE DEFRERE?

What happened at IMAGERIE MEDICALE DEFRERE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: profit of € 71,660 (▲ 4% vs 2024). Source: NBB ↗
Jan 1, 2012 New establishment in Seraing. KBO
Nov 30, 2011 Start of the company according to the CBE. KBO

In short

From € 52,093 profit in 2022 to € 71,660 profit in 2025.

Paid € 109,146 in corporate taxes since 2022.

Best year ever: 2025, with € 71,660 profit.

Paid out € 200,135 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at IMAGERIE MEDICALE DEFRERE? We notify you, reason included.

Follow IMAGERIE MEDICALE DEFRERE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit